K-Ras4A Trafficking and Signaling

描述（由申请人提供）：Ras癌基因是人类癌症中最常见的突变基因。Ras蛋白是控制生长、增殖和存活的关键细胞途径的小GTP酶，其失调广泛地涉及癌症。的 三个Ras基因中，KRAS的突变在人类肿瘤中最常见。KRAS基因编码两种剪接变体：K-Ras 4A和K-Ras 4 B。已经做了很多工作来表征Ras生物学，但绝大多数研究都忽略了K-Ras 4A亚型，尽管它作为原始K-Ras病毒癌基因的重要性。最近的研究已经开始暗示K-Ras 4A在癌症中的作用比以前假设的更大，但对K-Ras 4A蛋白仍然知之甚少。这项拟议的工作试图通过阐明K-Ras 4A的细胞生物学来纠正这一点，具有两个特定的目标。首先，我们将研究K-Ras 4A定位的靶向信号以及它们是如何被调节的。由于Ras信号传导需要膜缔合，因此确定K-Ras 4A如何在细胞内运输对于理解它如何发挥其信号作用至关重要。我们假设K-Ras 4A通过棕榈酰化和多元相互作用被运输到质膜，并将用活细胞成像研究来测试这一点。其次，我们将探讨K-Ras 4A在介导肿瘤发生中的作用。我们将在人类癌细胞系中研究K-Ras 4A的相对表达水平和对生存和肿瘤发生的依赖性，并研究两种K-Ras亚型的相对信号输出。我们从这些研究中的发现将提供一个更好的了解这种难以捉摸的亚型，并有助于我们的Ras生物学知识。这项工作也将对K-Ras驱动的抗癌药物的设计和开发产生重大影响。

DESCRIPTION (provided by applicant): Ras oncogenes are the most frequently mutated in human cancer. The Ras proteins are small GTPases that control critical cellular pathways for growth, proliferation, and survival, dysregulation of which is implicated extensively in cancer. Of the three Ras genes, mutations in KRAS are the most frequently found in human tumors. There are two splice variants encoded by the KRAS gene: K-Ras4A and K-Ras4B. Much work has been done to characterize Ras biology, but the vast majority of studies have overlooked the K-Ras4A isoform, despite its importance as the original K-Ras viral oncogene. Recent studies have begun to implicate a greater role for K-Ras4A in cancer than previously assumed, but little is still known about the K-Ras4A protein. This proposed work seeks to rectify this by elucidating the cell biology of K- Ras4A with two specific aims. First, we will investigate the targeting signas for K-Ras4A localization and how they are regulated. As membrane association is required for Ras signaling, determining how K-Ras4A is trafficked within the cell is critical in understanding how it exerts its signaling effects. We hypothesize that K-Ras4A is trafficked to the plasma membrane by combined palmitoylation and polybasic interactions, and will test this with live cell imaging studies. Second, we will explore the role that K-Ras4A plays in mediating oncogenesis. We will examine in human cancer cell lines the relative expression levels and dependence on K-Ras4A for survival and tumorigenesis, and study the relative signaling outputs of the two K-Ras isoforms. Our findings from these studies will provide a better understanding of this elusive isoform and contribute to our knowledge of Ras biology. This work will also have significant implications for the design and development of drugs against cancers driven by K-Ras.